Thailand's healthcare system could generate ~2.1% GDP impact by leveraging medical research, health data, and innovation to prevent NCDs and attract biotech investment, rather than treating it solely as an expense. Siriraj proposes a two-tier screening system targeting 15–30 million working-age citizens with basic checks, then precision medicine + genetic testing for ~500k high-risk individuals, feeding a National Genomics Database to drive drug R&D and medical innovation tailored to Thai populations.